Coronary Intervention & Surgery

The older patients get, the higher their risk of death or bleeding after percutaneous coronary intervention (PCI). But a new study from a Japanese PCI registry suggests a transradial approach can prevent some of those complications, particularly in nonagenarians.

Delay to hospital presentation and suboptimal post-percutaneous coronary intervention (PCI) TIMI flow grades are both independently associated with excess mortality in women who suffer ST-segment elevation myocardial infarction (STEMI), according to a study that sought to better define the disproportionate sex gap in STEMI mortality.

Overlapping surgery—in which a surgeon moves from one procedure to the next before the first is finished, leaving junior surgeons and trainees to wrap up the noncritical portions of the surgery—isn’t associated with increased mortality or post-op complications in most cases. But, according to a study published in JAMA Feb. 26, it can raise the risk of adverse events in high-risk patients and those undergoing coronary artery bypass graft (CABG) surgery.

Two of Medtronic’s drug-eluting stents (DES)—the Resolute Onyx and the Resolute Integrity—have been granted FDA approval to treat coronary artery disease patients with chronic total occlusion (CTO), the company announced Feb. 26.

Women see worse outcomes than men after thoracic aortic surgery requiring hypothermic circulatory arrest (HCA), researchers reported in the Feb. 26 edition of Circulation.

The average cardiovascular surgeon drives nearly $3.7 million in net revenue each year for a hospital system, the most among 18 physician specialties included in a survey of hospital chief financial officers. Invasive cardiologists weren’t far behind, ranking No. 2 at almost $3.5 million per year.

Patients with coronary artery disease (CAD) enrolled in private insurance plans through Medicare Advantage (MA) are more likely to receive guideline-recommended medications for secondary prevention than those in fee-for-service Medicare, according to a new analysis in JAMA Cardiology. But that wasn't tied to improvements in blood pressure or cholesterol levels.

The ultra-thin Orsiro drug-eluting stent (DES) has received FDA approval and is now commercially available in the United States, device manufacturer Biotronik announced Feb. 22.

Individuals undergoing cardiac surgery might benefit from a pre-scheduled postoperative cocktail of intravenous (IV) acetaminophen and either propofol or dexmedetomidine, according to Harvard researchers who found the common painkiller could reduce in-hospital delirium in older patients.

Five-year survival rates and cardiovascular outcomes are similar between elderly patients who undergo both off- and on-pump coronary artery bypass grafting (CABG), according to research out of Germany.

A simple educational initiative designed to show cardiac surgeons how often they used blood transfusions—and how much they cost—helped one heart center significantly cut its rate of blood utilization and save a projected $500,000 each year.

Placing homemade shields under the angiographic table during percutaneous coronary procedures cut operators’ exposure to radiation at the pelvic level by a median of 72 percent, according to a single-center study in Circulation: Cardiovascular Interventions.